Cystic fibrosis presents extraordinary health burdens for patients and financial challenges for their families. Thanks to tremendous advances in medical treatments, more young adults with CF are living longer, healthier lives than ever before, and many more are pursuing dreams of higher education. Cystic fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in
For 16 years, Solvay Pharmaceuticals has awarded scholarships to high-achieving students with CF to encourage their pursuit of educational goals. The Scholarship is one aspect of the SolvayCARES program, which was created to address the specific needs of this patient population by providing support in a variety of formats throughout their lives as patients' needs evolve with age — such as upon graduation from high school.
"The SolvayCARES Scholarship helped ease the financial responsibility of my higher education and allowed me to focus on what really matters — earning my doctoral degree in clinical psychology so that I can pursue my dream of working in clinical therapy with individuals affected by chronic illnesses and those connected to them," said Samantha Pelican Monson, a 2007 SolvayCARES Scholarship recipient and doctoral student at the
This year's SolvayCARES Scholarship program offers a new opportunity with the launch of the Thriving Student Achiever award. This winner will earn a total of
"At Solvay Pharmaceuticals, we believe that reaching the milestone of graduation signifies tremendous victory for young people with CF and their families, and demonstrates courage and commitment," said Dr.
Winners of the SolvayCARES Scholarship and Thriving Student Achiever award receive a one-year scholarship for post-secondary study of any kind through an accredited program; winners' courses of study can range from vocational school to undergraduate degrees to doctoral work. Winners are determined through an application process focusing on creativity, academic excellence, community involvement, ability to serve as a role model in the CF community and financial need. Applications are due in early summer each year and the application form can be viewed via the SolvayCARES Scholarship Web site.
For more than 20 years, Solvay Pharmaceuticals has supported the CF community through SolvayCARES programs that offer nutritional, educational and financial resources. This support is provided at no cost to patients and includes: free CREON(R) (Pancrelipase Delayed-Release Capsules, USP) and multivitamins to patients for the first three years of life; nutritional drink supplements and multivitamins for children, teenagers and adults; and educational resources that address patients' evolving needs as they enter different life stages. Since 1993, Solvay Pharmaceuticals has awarded more than 500 scholarships for post-secondary education, totaling more than
About Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals Inc., of
Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology, and men's and women's health. Its 2007 sales were
SOLVAY is an international chemical and pharmaceutical Group with headquarters in
(1) Cystic Fibrosis Foundation. About Cystic Fibrosis. Accessed
Contact: Neil Hirsch Manager, U.S. Corporate Communications Solvay Pharmaceuticals, Inc. 770-578-2170 firstname.lastname@example.org Jane Petrino Senior Account Supervisor Ruder Finn 212-593-5805 email@example.com
SOURCE Solvay Pharmaceuticals, Inc.